首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Virtual screening and bioassay study of novel inhibitors for dengue virus mRNA cap (nucleoside-2'O)-methyltransferase
Authors:Luzhkov Victor B  Selisko Barbara  Nordqvist Anneli  Peyrane Frédéric  Decroly Etienne  Alvarez Karine  Karlen Anders  Canard Bruno  Qvist Johan
Institution:

aDepartment of Cell and Molecular Biology, Uppsala University, BMC, Box 596, S-751 24 Uppsala, Sweden

bCentre National de la Recherche Scientifique and Universités d’Aix-Marseille I et II, UMR 6098, Architecture et Fonction des Macromolécules Biologiques, AFMB-CNRS-ESIL, Case 925, 163 Avenue de Luminy, 13288 Marseille Cedex 9, France

cDepartment of Medicinal Chemistry, Uppsala University, BMC, Box 574, S-751 23 Uppsala, Sweden

Abstract:We report high-throughput structure-based virtual screening of putative Flavivirus 2′-O-methyltransferase inhibitors together with results from subsequent bioassay tests of selected compounds. Potential inhibitors for the S-adenosylmethionine binding site were explored using 2D similarity searching, pharmacophore filtering and docking. The inhibitory activities of 15 top-ranking compounds from the docking calculations were tested on a recombinant methyltransferase with the RNA substrate 7MeGpppAC5. Local and global docking simulations were combined to estimate the ligand selectivity for the target site. The results of the combined computational and experimental screening identified a novel inhibitor, with a previously unknown scaffold, that has an IC50 value of 60 μM.
Keywords:Flavivirus methyltransferase inhibitor  Drug design  Virtual screening  Docking
本文献已被 ScienceDirect PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号